American College of Rheumatology Guidance for <scp>COVID</scp> ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5-Reference-Cited by-同舟云学术

American College of Rheumatology Guidance for COVID ‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5

Published:2022-11-08 Issue:1 Volume:75 Page:
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Curtis Jeffrey R.¹^ORCID,Johnson Sindhu R.²^ORCID,Anthony Donald D.³^ORCID,Arasaratnam Reuben J.⁴,Baden Lindsey R.⁵,Bass Anne R.⁶^ORCID,Calabrese Cassandra⁷,Gravallese Ellen M.⁵,Harpaz Rafael⁸,Kroger Andrew⁹,Sadun Rebecca E.¹⁰^ORCID,Turner Amy S.¹¹^ORCID,Williams Eleanor Anderson¹²,Mikuls Ted R.¹³^ORCID

Affiliation:

1. University of Alabama at Birmingham

2. Toronto Western Hospital Mount Sinai Hospital, and University of Toronto Toronto Ontario Canada

3. Louis Stokes Cleveland VA Medical Center MetroHealth Medical Center, and Case Western Reserve University Cleveland Ohio

4. VA North Texas Health Care System and University of Texas Southwestern Medical Center Dallas

5. Brigham and Women's Hospital Boston Massachusetts

6. Hospital for Special Surgery and Weill Cornell Medicine New York New York

7. Cleveland Clinic Cleveland Ohio

8. Harpaz Herman Consultants Atlanta Georgia

9. CDC Atlanta Georgia

10. Duke University Durham North Carolina

11. American College of Rheumatology Atlanta Georgia

12. The Permanente Medical Group Union City California

13. University of Nebraska Medical Center and VA Nebraska–Western Iowa Health Care System Omaha

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42372

Reference110 articles.

1. Common language description of the term rheumatic and musculoskeletal diseases (RMDs) for use in communication with the lay public, healthcare providers, and other stakeholders endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR);Van der Heijde D;Arthritis Rheumatol,2018

2. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 3

3. US Food and Drug Administration.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document Pfizer‐BioNTech COVID‐19 vaccine. December 2020. URL:https://www.fda.gov/media/144245/download.

4. US Food and Drug Administration.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document Moderna COVID‐19 vaccine. December 2020. URL:https://www.fda.gov/media/144434/download.

5. 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and radiological evaluation of systemic lupus erythematosus, Research question: Evaluation of lupus cases in corona infection;2024-08-22

2. Breakthrough SARS-CoV-2 infection in fully vaccinated patients with systemic lupus erythematosus: results from the COVID-19 Vaccination in Autoimmune Disease (COVAD) study;Rheumatology International;2024-08-13

3. Clinical outcomes and risk factors in patients with COVID‐19 and autoimmune rheumatic diseases: insights from a major Australian hospital study;Internal Medicine Journal;2024-08-13

4. COVID-19 vaccine updates for people under different conditions;Science China Life Sciences;2024-07-29

5. 4th booster-dose SARS-CoV-2 heterologous and homologous vaccination in rheumatological patients;Frontiers in Immunology;2024-07-26